Silencing the intestinal GUCY2C tumor suppressor axis requires APC loss of heterozygosity

References

• Siegel RL, SaHSRACSA G, Miller KD, SaHSRACSA G, Jemal A, SaHSRACSA G. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30. doi:10.3322/caac.21590.
   PubMed Web of Science ®Google Scholar
• Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW. Apc mutations occur early during colorectal tumorigenesis. Nature. 1992;359:235–237. doi:10.1038/359235a0.
   PubMed Web of Science ®Google Scholar
• Fodde R, Smits R, Clevers H. Apc, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer. 2001;1:55–67. doi:10.1038/35094067.
   PubMed Web of Science ®Google Scholar
• Miyoshi Y, Ando H, Nagase H, Nishisho I, Horii A, Miki Y, Mori T, Utsunomiya J, Baba S, Petersen G, et al. Germ-line mutations of the apc gene in 53 familial adenomatous polyposis patients. Proc Nat Acad Sci. 1992;89:4452. doi:10.1073/pnas.89.10.4452.
   PubMed Web of Science ®Google Scholar
• Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol. 2011;6:479–507. doi:10.1146/annurev-pathol-011110-130235.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Hata K, Hirose Y, Hara A, Sugie S, Kuno T, Yoshimi N, Tanaka T, Mori H. Microadenomatous lesions involving loss of apc heterozygosity in the colon of adult apc(min/+) mice. Cancer Res. 2002;62:6367–6370.
   PubMed Web of Science ®Google Scholar
• Sameer AS. Colorectal cancer: molecular mutations and polymorphisms. Front Oncol. 2013;3:114. doi:10.3389/fonc.2013.00114.
   PubMedGoogle Scholar
• Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, Aoki T, Miki Y, Mori T, Nakamura Y, et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet. 1992;1:229–233. doi:10.1093/hmg/1.4.229.
   PubMedGoogle Scholar
• Miyaki M, Iijima T, Kimura J, Yasuno M, Mori T, Hayashi Y, Koike M, Shitara N, Iwama T, Kuroki T. Frequent mutation of beta-catenin and apc genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res. 1999;59:4506.
   PubMed Web of Science ®Google Scholar
• Nieuwenhuis MH, Vasen HFA. Correlations between mutation site in apc and phenotype of familial adenomatous polyposis (fap): A review of the literature. Crit Rev Oncol Hematol. 2007;61:153–161. doi:10.1016/j.critrevonc.2006.07.004.
   PubMed Web of Science ®Google Scholar
• Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, Zauber AG, de Boer J, Fireman BH, Schottinger JE, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298–1306. doi:10.1056/NEJMoa1309086.
   PubMed Web of Science ®Google Scholar
• Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of beta-catenin-tcf signaling in colon cancer by mutations in beta-catenin or apc. Science. 1997;275:1787–1790. doi:10.1126/science.275.5307.1787.
   PubMed Web of Science ®Google Scholar
• Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the apc/β-catenin/tcf pathway in colorectal cancer. Cancer Res. 1998;58:1130.
   PubMed Web of Science ®Google Scholar
• Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. Constitutive transcriptional activation by a beta-catenin-tcf complex in apc-/- colon carcinoma. Science. 1997;275:1784–1787. doi:10.1126/science.275.5307.1784.
   PubMed Web of Science ®Google Scholar
• Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012;149:1192–1205. doi:10.1016/j.cell.2012.05.012.
   PubMed Web of Science ®Google Scholar
• Arshad N, Visweswariah SS. The multiple and enigmatic roles of guanylyl cyclase c in intestinal homeostasis. FEBS Lett. 2012;586:2835–2840. doi:10.1016/j.febslet.2012.07.028.
   PubMed Web of Science ®Google Scholar
• Lin JE, Li P, Snook AE, Schulz S, Dasgupta A, Hyslop TM, Gibbons AV, Marszlowicz G, Pitari GM, Waldman SA, et al. The hormone receptor gucy2c suppresses intestinal tumor formation by inhibiting akt signaling. Gastroenterology. 2010;138:241–254. doi:10.1053/j.gastro.2009.08.064.
   PubMed Web of Science ®Google Scholar
• Li P, Lin JE, Chervoneva I, Schulz S, Waldman SA, Pitari GM. Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase c restricts the proliferating compartment in intestine. Am J Pathol. 2007;171:1847–1858. doi:10.2353/ajpath.2007.070198.
   PubMed Web of Science ®Google Scholar
• Li P, Schulz S, Bombonati A, Palazzo JP, Hyslop TM, Xu Y, Baran AA, Siracusa LD, Pitari GM, Waldman SA, et al. Guanylyl cyclase c suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity. Gastroenterology. 2007;133(2):599–607. doi:10.1053/j.gastro.2007.05.052.
   PubMed Web of Science ®Google Scholar
• Lin JE, Snook AE, Li P, Stoecker BA, Kim GW, Magee MS, Garcia AVM, Valentino MA, Hyslop T, Schulz S, et al. Gucy2c opposes systemic genotoxic tumorigenesis by regulating akt-dependent intestinal barrier integrity. PLoS One. 2012;7(2):e31686. doi:10.1371/journal.pone.0031686.
   PubMed Web of Science ®Google Scholar
• Gibbons AV, Lin JE, Kim GW, Marszalowicz GP, Li P, Stoecker BA, Blomain ES, Rattan S, Snook AE, Schulz S, et al. Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer. Cancer Res. 2013;73(22):6654–6666. doi:10.1158/0008-5472.CAN-13-0887.
   PubMed Web of Science ®Google Scholar
• Brenna O, Furnes MW, Munkvold B, Kidd M, Sandvik AK, Gustafsson BI. Cellular localization of guanylin and uroguanylin mrnas in human and rat duodenal and colonic mucosa. Cell Tissue Res. 2016;365(2):331–341. doi:10.1007/s00441-016-2393-y.
   PubMed Web of Science ®Google Scholar
• Ikpa PT, Sleddens HF, Steinbrecher KA, Peppelenbosch MP, de Jonge HR, Smits R, Bijvelds MJC. Guanylin and uroguanylin are produced by mouse intestinal epithelial cells of columnar and secretory lineage. Histochem Cell Biol. 2016;146(4):445–455. doi:10.1007/s00418-016-1453-4.
   PubMed Web of Science ®Google Scholar
• Whitaker TL, Witte DP, Scott MC, Cohen MB. Uroguanylin and guanylin: distinct but overlapping patterns of messenger rna expression in mouse intestine. Gastroenterology. 1997;113:1000–1006. doi:10.1016/S0016-5085(97)70197-5.
   PubMed Web of Science ®Google Scholar
• Vaandrager AB. Structure and function of the heat-stable enterotoxin receptor/guanylyl cyclase c. Mol Cell Biochem. 2002;230:73–83. doi:10.1023/A:1014231722696.
   PubMed Web of Science ®Google Scholar
• Kuhn M. Molecular physiology of membrane guanylyl cyclase receptors. Physiol Rev. 2016;96:751–804. doi:10.1152/physrev.00022.2015.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi:10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Li P, Lin JE, Snook AE, Waldman SA. St-producing e. Coli oppose carcinogen-induced colorectal tumorigenesis in mice. Toxins (Basel). 2017;9:279. doi:10.3390/toxins9090279.
   Web of Science ®Google Scholar
• Shailubhai K, Yu HH, Karunanandaa K, Wang JY, Eber SL, Wang Y, Joo NS, Kim HD, Miedema BW, Abbas SZ, et al. Uroguanylin treatment suppresses polyp formation in the apc(min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic gmp. Cancer Res. 2000;60:5151–5157.
   PubMed Web of Science ®Google Scholar
• Sharman SK, Islam BN, Hou Y, Singh N, Berger FG, Sridhar S, Yoo W, Browning DD. Cyclic-GMP–Elevating agents suppress polyposis in Apc min mice by targeting the preneoplastic epithelium. Cancer Prev Res (Phila). 2018;11:81–92. doi:10.1158/1940-6207.CAPR-17-0267.
   PubMed Web of Science ®Google Scholar
• Steinbrecher KA, Tuohy TM, Heppner Goss K, Scott MC, Witte DP, Groden J, Cohen MB. Expression of guanylin is downregulated in mouse and human intestinal adenomas. Biochem Biophys Res Commun. 2000;273(1):225–230. doi:10.1006/bbrc.2000.2917.
   PubMed Web of Science ®Google Scholar
• Wilson C, Lin JE, Li P, Snook AE, Gong J, Sato T, Liu C, Girondo MA, Rui H, Hyslop T, et al. The paracrine hormone for the gucy2c tumor suppressor, guanylin, is universally lost in colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2328–2337. doi:10.1158/1055-9965.EPI-14-0440.
   PubMed Web of Science ®Google Scholar
• Bashir B, Merlino DJ, Rappaport JA, Gnass E, Palazzo JP, Feng Y, Fearon ER, Snook AE, Waldman SA. Silencing the guca2a-gucy2c tumor suppressor axis in cin, serrated, and msi colorectal neoplasia. Hum Pathol. 2019;87:103–114. doi:10.1016/j.humpath.2018.11.032.
   PubMed Web of Science ®Google Scholar
• Blomain ES, Rappaport JA, Pattison AM, Bashir B, Caparosa E, Stem J, Snook AE, Waldman SA. Apc-β-catenin-tcf signaling silences the intestinal guanylin-gucy2c tumor suppressor axis. Cancer Biol Ther. 2020;21(5):441–451. doi:10.1080/15384047.2020.1721262.
   PubMed Web of Science ®Google Scholar
• Carrithers SL, Barber MT, Biswas S, Parkinson SJ, Park PK, Goldstein SD, Waldman SA. Guanylyl cyclase c is a selective marker for metastatic colorectal tumors in human extraintestinal tissues. Proc Natl Acad Sci U S A. 1996;93(25):14827–14832. doi:10.1073/pnas.93.25.14827.
   PubMed Web of Science ®Google Scholar
• Carrithers SL, Parkinson SJ, Goldstein S, Park P, Robertson DC, Waldman SA. Escherichia coli heat-stable toxin receptors in human colonic tumors. Gastroenterology. 1994;107:1653–1661. doi:10.1016/0016-5085(94)90804-4.
   PubMed Web of Science ®Google Scholar
• Danaee H, Kalebic T, Wyant T, Fassan M, Mescoli C, Gao F, Trepicchio WL, Rugge M. Consistent expression of guanylyl cyclase-c in primary and metastatic gastrointestinal cancers. PLoS One. 2017;12:e0189953. doi:10.1371/journal.pone.0189953.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–337. doi:10.1038/nature11252.
   PubMed Web of Science ®Google Scholar
• Darwich AS, Aslam U, Ashcroft DM, Rostami-Hodjegan A. Meta-analysis of the turnover of intestinal epithelia in preclinical animal species and humans. Drug Metab Dispos. 2014;42:2016. doi:10.1124/dmd.114.058404.
   PubMed Web of Science ®Google Scholar
• Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 2014;15:19–33. doi:10.1038/nrm3721.
   PubMed Web of Science ®Google Scholar
• Creamer B, Shorter RG, Bamforth J. The turnover and shedding of epithelial cells. I. The turnover in the gastro-intestinal tract. Gut. 1961;2:110–118. doi:10.1136/gut.2.2.110.
   PubMed Web of Science ®Google Scholar
• Li P, Waldman SA. Corruption of homeostatic mechanisms in the guanylyl cyclase c signaling pathway underlying colorectal tumorigenesis. Cancer Biol Ther. 2010;10:211–218. doi:10.4161/cbt.10.3.12539.
   PubMed Web of Science ®Google Scholar
• Vermeulen L, Snippert HJ. Stem cell dynamics in homeostasis and cancer of the intestine. Nat Rev Cancer. 2014;14:468–480. doi:10.1038/nrc3744.
   PubMed Web of Science ®Google Scholar
• Steinbrecher KA, Harmel-Laws E, Garin-Laflam MP, Mann EA, Bezerra LD, Hogan SP, Cohen MB. Murine guanylate cyclase c regulates colonic injury and inflammation. J Immunol. 2011;186:7205–7214. doi:10.4049/jimmunol.1002469.
   PubMed Web of Science ®Google Scholar
• Brierley SM. Guanylate cyclase-c receptor activation: unexpected biology. Curr Opin Pharmacol. 2012;12:632–640. doi:10.1016/j.coph.2012.10.005.
   PubMed Web of Science ®Google Scholar
• Lan D, Niu J, Miao J, Dong X, Wang H, Yang G, Wang K, Miao Y. Expression of guanylate cyclase-c, guanylin, and uroguanylin is downregulated proportionally to the ulcerative colitis disease activity index. Sci Rep. 2016;6:25034. doi:10.1038/srep25034.
   PubMed Web of Science ®Google Scholar
• Lin JE, Colon-Gonzalez F, Blomain E, Kim GW, Aing A, Stoecker B, Rock J, Snook AE, Zhan T, Hyslop TM, et al. Obesity-induced colorectal cancer is driven by caloric silencing of the guanylin-gucy2c paracrine signaling axis. Cancer Res. 2016;76:339–346. doi:10.1158/0008-5472.CAN-15-1467-T.
   PubMed Web of Science ®Google Scholar
• Chang WL, Masih S, Thadi A, Patwa V, Joshi A, Cooper HS, Palejwala VA, Clapper ML, Shailubhai K. Plecanatide-mediated activation of guanylate cyclase-C suppresses inflammation-induced colorectal carcinogenesis in Apc +/Min-FCCC mice. World J Gastrointest Pharmacol Ther. 2017;8:47–59. doi:10.4292/wjgpt.v8.i1.47.
   PubMedGoogle Scholar
• El Marjou F, Janssen KP, Chang BH, Li M, Hindie V, Chan L, Louvard D, Chambon P, Metzger D, Robine S, et al. Tissue-specific and inducible cre-mediated recombination in the gut epithelium. Genesis. 2004;39:186–193. doi:10.1002/gene.20042.
   PubMed Web of Science ®Google Scholar
• Schulz S, Lopez MJ, Kuhn M, Garbers DL. Disruption of the guanylyl cyclase-c gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice. J Clin Invest. 1997;100:1590–1595. doi:10.1172/JCI119683.
   PubMed Web of Science ®Google Scholar
• Qian X, Prabhakar S, Nandi A, Visweswariah SS, Goy MF. Expression of gc-c, a receptor-guanylate cyclase, and its endogenous ligands uroguanylin and guanylin along the rostrocaudal axis of the intestine*. Endocrinology. 2000;141:3210–3224. doi:10.1210/endo.141.9.7644.
   PubMed Web of Science ®Google Scholar